Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome (Q92896571)
Jump to navigation
Jump to search
scientific article published on 20 June 2019
Language | Label | Description | Also known as |
---|---|---|---|
English | Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome |
scientific article published on 20 June 2019 |
Statements
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome (English)